ACP

Acuta Capital Partners Portfolio holdings

AUM $96.8M
1-Year Est. Return 275.72%
This Quarter Est. Return
1 Year Est. Return
+275.72%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$96.8M
AUM Growth
+$25.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
36
New
Increased
Reduced
Closed

Top Buys

1
+$4.53M
2
+$2.94M
3
+$2.21M
4
KRYS icon
Krystal Biotech
KRYS
+$1.87M
5
OCUL icon
Ocular Therapeutix
OCUL
+$1.76M

Top Sells

1
+$5.31M
2
+$3.64M
3
+$2.7M
4
ASND icon
Ascendis Pharma
ASND
+$2.54M
5
RVMD icon
Revolution Medicines
RVMD
+$2.21M

Sector Composition

1 Healthcare 99.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
26
Revolution Medicines
RVMD
$23.4B
$393K 0.41%
8,411
-47,282
UNCY icon
27
Unicycive Therapeutics
UNCY
$142M
$262K 0.27%
59,985
-2,914
NUVB.WS icon
28
Nuvation Bio Inc Warrants
NUVB.WS
$19.7M
$18.4K 0.02%
90,832
AKRO
29
DELISTED
Akero Therapeutics
AKRO
– –
-19,772
LQDA icon
30
Liquidia Corp
LQDA
$3.48B
– –
-75,876
RARE icon
31
Ultragenyx Pharmaceutical
RARE
$2.32B
– –
-23,814
SLNO icon
32
Soleno Therapeutics
SLNO
$2.28B
– –
-63,436
TRVI icon
33
Trevi Therapeutics
TRVI
$1.47B
– –
-493,735
BBOT
34
BridgeBio Oncology
BBOT
$963M
– –
-187,257
RAPP
35
Rapport Therapeutics
RAPP
$1.31B
– –
-20,000
ARTV
36
Artiva Biotherapeutics
ARTV
$117M
– –
-45,456
1
2